03/30/2007
Federal Register Proposed rule: FDA is reopening until 5/14, the comment period for a proposed rule published in the 1/12 Federal ...03/30/2007
Federal Register Final rule: FDA makes editorial changes to citations in the regulations on the prescription-exemption procedure a...03/30/2007
Federal Register Notice: FDA is making available a draft guidance for industry and review staff, Target Product Profile — A ...03/29/2007
Federal Register Notice: FDA has determined the regulatory review period for Retevase (reteplase) is 1,919 days for extending a pa...03/29/2007
Federal Register Notice: FDA's Office of Women's Health will hold a “Workshop to Develop a Women's Health Information Sharin...03/29/2007
Federal Register Notice: FDA has determined the regulatory review period for Astellas Pharma’s Vaprisol is 2,796 days for ex...03/29/2007
Federal Register Notice: FDA will hold the public meeting entitled: “Meeting to Present Work-in-Progress on a Method for Ran...03/29/2007
Federal Register Final rule: FDA is issuing a final rule establishing that OTC laxative drug products in granular dosage form cont...